Informação detalhada
- Estado
- Aberto
- Referência
- HORIZON-HLTH-2025-01-DISEASE-01
- Data de publicação
- 21 de maio de 2025 no Funding and Tenders Portal
- Data de abertura
- Modelo de prazo
- Fase única
- Data-limite
- 16 de setembro de 2025, 17:00 (CEST)
- Programme Sector
- Health
- Programme
- Horizon Europe
- Horizon Europe Cluster 1: Health
Descrição
Under the topic HORIZON-HLTH-2025-01-DISEASE-01 should aim to deliver results that are directed, tailored towards and contributing to most of the following expected outcomes:
- Researchers and developers make the best use of the state-of-the-art knowledge and resources for an effective development of new treatment options for patients suffering from difficult-to-treat infections.
- Healthcare professionals and people living with difficult-to-treat infections are ultimately provided with the availability of clinically useful phage therapies.
- Regulators are provided with quantifiable, verifiable and replicable data on safety and efficacy of phage therapy for human use and move faster towards market approval of novel phage-based therapies against antimicrobial resistant infections.
- Citizens are engaged and informed on innovative phage-based treatments as alternative therapeutic options complementary to antibiotics.
Interested parties can find more information and apply on the Funding and Tenders Portal.